ID   FGFR4_HUMAN             Reviewed;         802 AA.
AC   P22455; O43785; Q14309; Q71TW8; Q8TDA0;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   02-NOV-2010, entry version 125.
DE   RecName: Full=Fibroblast growth factor receptor 4;
DE            Short=FGFR-4;
DE            EC=2.7.10.1;
DE   AltName: CD_antigen=CD334;
DE   Flags: Precursor;
GN   Name=FGFR4; Synonyms=JTK2, TKF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=91224085; PubMed=1709094;
RA   Partanen J.M., Maekelae T.P., Eerola E., Korhonen J., Hirvonen H.,
RA   Claesson-Welsh L., Alitalo K.;
RT   "FGFR-4, a novel acidic fibroblast growth factor receptor with a
RT   distinct expression pattern.";
RL   EMBO J. 10:1347-1354(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   MEDLINE=93194827; PubMed=7680645;
RA   Ron D., Reich R., Chedid M., Lengel C., Cohen O.E., Chan A.M.,
RA   Neufeld G., Miki T., Tronick S.R.;
RT   "Fibroblast growth factor receptor 4 is a high affinity receptor for
RT   both acidic and basic fibroblast growth factor but not for
RT   keratinocyte growth factor.";
RL   J. Biol. Chem. 268:5388-5394(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT LEU-136, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Intestine;
RX   MEDLINE=20133241; PubMed=10631118; DOI=10.1006/bbrc.1999.2010;
RA   Takaishi S., Sawada M., Morita Y., Seno H., Fukuzawa H., Chiba T.;
RT   "Identification of a novel alternative splicing of human FGF receptor
RT   4: soluble-form splice variant expressed in human gastrointestinal
RT   epithelial cells.";
RL   Biochem. Biophys. Res. Commun. 267:658-662(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=98119018; PubMed=9457674; DOI=10.1007/s003359900703;
RA   Kostrzewa M., Muller U.;
RT   "Genomic structure and complete sequence of the human FGFR4 gene.";
RL   Mamm. Genome 9:131-135(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-136.
RA   Lind D.L., Cox D.R.;
RT   "Sequence variation in fibroblast growth factor receptors 3 and 4.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-10; LEU-136 AND
RP   ARG-388.
RG   NIEHS SNPs program;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-136.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 609-676.
RC   TISSUE=Blood;
RX   MEDLINE=91062389; PubMed=2247464; DOI=10.1073/pnas.87.22.8913;
RA   Partanen J., Maekelae T.P., Alitalo R., Lehvaeslaiho H., Alitalo K.;
RT   "Putative tyrosine kinases expressed in K-562 human leukemia cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8913-8917(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 22-38.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-573, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-10; LEU-136; ALA-179; SER-426;
RP   ASN-516; MET-550; THR-712 AND ASN-772.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for acidic fibroblast growth factor. Does not
CC       bind to basic fibroblast growth factor. Binds FGF19.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with KLB (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Note=Isoform 2 may be secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22455-1; Sequence=Displayed;
CC       Name=2; Synonyms=Soluble-form;
CC         IsoId=P22455-2; Sequence=VSP_035108;
CC   -!- TISSUE SPECIFICITY: Expressed in gastrointestinal epithelial
CC       cells, pancreas, and gastric and pancreatic cancer cell lines.
CC   -!- PTM: Glycosylated (By similarity).
CC   -!- PTM: Phosphorylated on tyrosine residue (By similarity).
CC       Phosphorylation requires the presence of a functional
CC       (phosphorylated) FGFR1 and not necessarily by means of FGFR
CC       heterodimerization (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fibroblast growth factor receptor subfamily.
CC   -!- SIMILARITY: Contains 3 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fgfr4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57205; CAA40490.1; -; mRNA.
DR   EMBL; L03840; AAB59389.1; -; mRNA.
DR   EMBL; AF202063; AAF27432.1; -; mRNA.
DR   EMBL; Y13901; CAA74200.1; -; Genomic_DNA.
DR   EMBL; AF487555; AAM13666.1; -; Genomic_DNA.
DR   EMBL; EF571596; ABQ01235.1; -; Genomic_DNA.
DR   EMBL; CH471195; EAW85036.1; -; Genomic_DNA.
DR   EMBL; BC011847; AAH11847.1; -; mRNA.
DR   EMBL; M59373; AAA63208.1; -; mRNA.
DR   IPI; IPI00304578; -.
DR   IPI; IPI00420109; -.
DR   PIR; S15345; TVHUF4.
DR   RefSeq; NP_002002.3; -.
DR   RefSeq; NP_075252.2; -.
DR   RefSeq; NP_998812.1; -.
DR   UniGene; Hs.165950; -.
DR   PDB; 1QCT; Model; -; B/E=36-353.
DR   PDBsum; 1QCT; -.
DR   ProteinModelPortal; P22455; -.
DR   SMR; P22455; 146-355, 454-747, 464-773.
DR   DIP; DIP-5149N; -.
DR   STRING; P22455; -.
DR   PhosphoSite; P22455; -.
DR   PRIDE; P22455; -.
DR   Ensembl; ENST00000292408; ENSP00000292408; ENSG00000160867.
DR   Ensembl; ENST00000393648; ENSP00000377259; ENSG00000160867.
DR   GeneID; 2264; -.
DR   KEGG; hsa:2264; -.
DR   UCSC; uc003mfl.1; human.
DR   CTD; 2264; -.
DR   GeneCards; GC05P176446; -.
DR   H-InvDB; HIX0200758; -.
DR   HGNC; HGNC:3691; FGFR4.
DR   HPA; CAB005196; -.
DR   HPA; HPA027273; -.
DR   HPA; HPA027369; -.
DR   HPA; HPA028251; -.
DR   MIM; 134935; gene.
DR   PharmGKB; PA28130; -.
DR   eggNOG; prNOG11483; -.
DR   HOVERGEN; HBG000345; -.
DR   OrthoDB; EOG93JFPX; -.
DR   PhylomeDB; P22455; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   Reactome; REACT_9470; Signaling by FGFR.
DR   DrugBank; DB00039; Palifermin.
DR   NextBio; 9195; -.
DR   ArrayExpress; P22455; -.
DR   Bgee; P22455; -.
DR   CleanEx; HS_FGFR4; -.
DR   Genevestigator; P22455; -.
DR   GermOnline; ENSG00000160867; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB.
DR   GO; GO:0005007; F:fibroblast growth factor receptor activity; IPI:MGI.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IGI:MGI.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020933; Tyr_kin_fibroblast_GF_rcpt_reg.
DR   InterPro; IPR016248; Tyr_kinase_fibroblast_GF_rcpt.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 3.
DR   PANTHER; PTHR23256:SF276; Tyr_kinase_fibroblast_GF_rcpt; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000628; FGFR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Receptor; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     21
FT   CHAIN        22    802       Fibroblast growth factor receptor 4.
FT                                /FTId=PRO_0000016787.
FT   TOPO_DOM     22    369       Extracellular (Potential).
FT   TRANSMEM    370    390       Helical; (Potential).
FT   TOPO_DOM    391    802       Cytoplasmic (Potential).
FT   DOMAIN       22    118       Ig-like C2-type 1.
FT   DOMAIN      152    240       Ig-like C2-type 2.
FT   DOMAIN      249    349       Ig-like C2-type 3.
FT   DOMAIN      467    755       Protein kinase.
FT   NP_BIND     473    481       ATP (By similarity).
FT   ACT_SITE    612    612       Proton acceptor (By similarity).
FT   BINDING     503    503       ATP (By similarity).
FT   MOD_RES     573    573       Phosphoserine.
FT   MOD_RES     643    643       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    112    112       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    258    258       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    290    290       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    311    311       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    322    322       N-linked (GlcNAc...) (Potential).
FT   DISULFID     57    101       Potential.
FT   DISULFID    172    224       Potential.
FT   DISULFID    271    333       Potential.
FT   VAR_SEQ     353    416       EEDPTWTAAAPEARYTDIILYASGSLALAVLLLLAGLYRGQ
FT                                ALHGRHPRPPATVQKLSRFPLAR -> GTGRIPHLTCDSLT
FT                                PAGRTKSPTL (in isoform 2).
FT                                /FTId=VSP_035108.
FT   VARIANT      10     10       V -> I (in dbSNP:rs1966265).
FT                                /FTId=VAR_029185.
FT   VARIANT     136    136       P -> L (in dbSNP:rs376618).
FT                                /FTId=VAR_042211.
FT   VARIANT     179    179       T -> A (in dbSNP:rs55675160).
FT                                /FTId=VAR_042212.
FT   VARIANT     388    388       G -> R (in dbSNP:rs351855).
FT                                /FTId=VAR_014797.
FT   VARIANT     426    426       G -> S (in dbSNP:rs55879131).
FT                                /FTId=VAR_046102.
FT   VARIANT     516    516       D -> N (in dbSNP:rs34158682).
FT                                /FTId=VAR_042213.
FT   VARIANT     529    529       R -> Q (in dbSNP:rs34284947).
FT                                /FTId=VAR_049720.
FT   VARIANT     550    550       V -> M (in breast pleomorphic lobular
FT                                sample; somatic mutation).
FT                                /FTId=VAR_046103.
FT   VARIANT     712    712       P -> T (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_046104.
FT   VARIANT     772    772       S -> N (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_046105.
FT   CONFLICT    121    121       L -> S (in Ref. 3; AAF27432).
FT   CONFLICT    194    194       E -> G (in Ref. 3; AAF27432).
FT   CONFLICT    297    297       D -> V (in Ref. 1; CAA40490).
FT   STRAND       45     47
FT   STRAND       65     67
FT   STRAND       75     81
FT   HELIX        93     95
FT   STRAND      100    102
FT   STRAND      114    116
FT   STRAND      160    163
FT   STRAND      168    171
FT   TURN        176    178
FT   TURN        180    183
FT   STRAND      189    191
FT   TURN        192    194
FT   STRAND      199    205
FT   STRAND      208    213
FT   HELIX       216    218
FT   STRAND      220    227
FT   STRAND      229    242
FT   STRAND      256    260
FT   STRAND      263    265
FT   STRAND      267    271
FT   STRAND      273    275
FT   STRAND      277    285
FT   STRAND      295    298
FT   STRAND      301    304
FT   STRAND      312    322
FT   HELIX       325    327
FT   STRAND      331    336
FT   STRAND      342    349
SQ   SEQUENCE   802 AA;  87954 MW;  B22B259831BB889F CRC64;
     MRLLLALLGV LLSVPGPPVL SLEASEEVEL EPCLAPSLEQ QEQELTVALG QPVRLCCGRA
     ERGGHWYKEG SRLAPAGRVR GWRGRLEIAS FLPEDAGRYL CLARGSMIVL QNLTLITGDS
     LTSSNDDEDP KSHRDPSNRH SYPQQAPYWT HPQRMEKKLH AVPAGNTVKF RCPAAGNPTP
     TIRWLKDGQA FHGENRIGGI RLRHQHWSLV MESVVPSDRG TYTCLVENAV GSIRYNYLLD
     VLERSPHRPI LQAGLPANTT AVVGSDVELL CKVYSDAQPH IQWLKHIVIN GSSFGADGFP
     YVQVLKTADI NSSEVEVLYL RNVSAEDAGE YTCLAGNSIG LSYQSAWLTV LPEEDPTWTA
     AAPEARYTDI ILYASGSLAL AVLLLLAGLY RGQALHGRHP RPPATVQKLS RFPLARQFSL
     ESGSSGKSSS SLVRGVRLSS SGPALLAGLV SLDLPLDPLW EFPRDRLVLG KPLGEGCFGQ
     VVRAEAFGMD PARPDQASTV AVKMLKDNAS DKDLADLVSE MEVMKLIGRH KNIINLLGVC
     TQEGPLYVIV ECAAKGNLRE FLRARRPPGP DLSPDGPRSS EGPLSFPVLV SCAYQVARGM
     QYLESRKCIH RDLAARNVLV TEDNVMKIAD FGLARGVHHI DYYKKTSNGR LPVKWMAPEA
     LFDRVYTHQS DVWSFGILLW EIFTLGGSPY PGIPVEELFS LLREGHRMDR PPHCPPELYG
     LMRECWHAAP SQRPTFKQLV EALDKVLLAV SEEYLDLRLT FGPYSPSGGD ASSTCSSSDS
     VFSHDPLPLG SSSFPFGSGV QT
//
